Literature DB >> 11050476

Adenovirus-mediated transfer of Fas ligand gene augments radiation-induced apoptosis in U-373MG glioma cells.

N Shinoura1, N Yamamoto, A Asai, T Kirino, H Hamada.   

Abstract

Most malignant astrocytomas (gliomas) express a high level of Fas, whereas the surrounding normal tissues such as neurons and astrocytes express a very low level of Fas. Thus, transduction of Fas ligand would selectively kill malignant astrocytoma cells. On the other hand, glioma cells harboring p53 mutation have been reported to be resistant to conventional therapies including radiation. To override the resistance mechanism of glioma cells with p53 mutation to radiation, we transduced U-373MG malignant astrocytoma (glioma) cells harboring mutant p53 with Fas ligand via an adenovirus (Adv) vector in combination with X-ray irradiation, and evaluated the degree of apoptosis. The degree of apoptosis in U-373MG cells infected with the Adv for Fas ligand (Adv-FL) and treated with irradiation (81%) was much higher than that in U-373MG cells infected with Adv-FL and not treated with irradiation (0.8%) or that in U-373MG cells infected with the control Adv for lacZ and treated with irradiation (5.0%). In U-373MG cells infected with Adv-FL, irradiation increased the expression of Fas ligand. Coincident with the increase in Fas ligand, there was a marked reduction in the caspase-3 level and a marked increase in the cleaved form of poly(ADP-ribose) polymerase (PARP), which are downstream components of Fas ligand-mediated apoptosis. This suggests that the enhanced activation of caspase-3 by the transduction of Fas ligand combined with irradiation, induced extensive apoptosis in U-373MG cells. In summary, transduction of Fas ligand may override the resistance mechanism to radiotherapy in glioma cells harboring p53 mutation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050476      PMCID: PMC5926259          DOI: 10.1111/j.1349-7006.2000.tb00883.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  37 in total

1.  Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells.

Authors:  S Fulda; C Scaffidi; T Pietsch; P H Krammer; M E Peter; K M Debatin
Journal:  Cell Death Differ       Date:  1998-10       Impact factor: 15.828

2.  Adenovirus-mediated overexpression of Fas induces apoptosis of gliomas.

Authors:  N Shinoura; M Ohashi; Y Yoshida; T Kirino; A Asai; M Hashimoto; H Hamada
Journal:  Cancer Gene Ther       Date:  2000-02       Impact factor: 5.987

3.  Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy.

Authors:  K Newton; A Strasser
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

4.  Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.

Authors:  C Gratas; Y Tohma; E G Van Meir; M Klein; M Tenan; N Ishii; O Tachibana; P Kleihues; H Ohgaki
Journal:  Brain Pathol       Date:  1997-07       Impact factor: 6.508

5.  Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase.

Authors:  Y Kanegae; G Lee; Y Sato; M Tanaka; M Nakai; T Sakaki; S Sugano; I Saito
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

6.  Thymocyte apoptosis induced by p53-dependent and independent pathways.

Authors:  A R Clarke; C A Purdie; D J Harrison; R G Morris; C C Bird; M L Hooper; A H Wyllie
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

7.  Activation of a CrmA-insensitive, p35-sensitive pathway in ionizing radiation-induced apoptosis.

Authors:  R Datta; H Kojima; D Banach; N J Bump; R V Talanian; E S Alnemri; R R Weichselbaum; W W Wong; D W Kufe
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

8.  Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.

Authors:  A Villunger; A Egle; M Kos; B L Hartmann; S Geley; R Kofler; R Greil
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

9.  Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

Authors:  P Saas; P R Walker; M Hahne; A L Quiquerez; V Schnuriger; G Perrin; L French; E G Van Meir; N de Tribolet; J Tschopp; P Y Dietrich
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

10.  Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy.

Authors:  N Shinoura; Y Yoshida; A Sadata; K I Hanada; S Yamamoto; T Kirino; A Asai; H Hamada
Journal:  Hum Gene Ther       Date:  1998-09-20       Impact factor: 5.695

View more
  6 in total

Review 1.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

Review 2.  Gene therapy for carcinoma of the breast.

Authors:  M A Stoff-Khalili; P Dall; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-06       Impact factor: 5.987

3.  Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma.

Authors:  Zhi-xiang Yang; Dong Wang; Ge Wang; Qin-hong Zhang; Jing-mao Liu; Po Peng; Xiao-hui Liu
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-31       Impact factor: 4.553

Review 4.  Chapter seven--Cancer treatment with gene therapy and radiation therapy.

Authors:  Sergey A Kaliberov; Donald J Buchsbaum
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

5.  Genetic control of wayward pluripotent stem cells and their progeny after transplantation.

Authors:  Maija Kiuru; Julie L Boyer; Timothy P O'Connor; Ronald G Crystal
Journal:  Cell Stem Cell       Date:  2009-04-03       Impact factor: 24.633

Review 6.  Apoptosis in glioma cells: review and analysis of techniques used for study with focus on the laser scanning cytometer.

Authors:  Bardia Amirlak; William T Couldwell
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.